Dr. Edward Kazuhisa Nomoto, MD

Dr. Nomoto practices at Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System.

Dr. Nomoto's NPI, 1861683245, was assigned on August 9, 2007. Dr. Nomoto graduated from Stanford University School Of Medicine in 2006. Dr. Nomoto holds California license A102820.

Dr. Nomoto's primary practice is Cedars-Sinai Medical Center, at 8700 Beverly Blvd, Los Angeles, CA 90048 in Los Angeles County. The practice phone is (310) 423-5000.

Dr. Nomoto's primary practice is Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System. Dr. Nomoto is also affiliated with Kaweah Health Medical Center. The medical group on file is Providence Saint John's Health Center. Dmand AI also links Dr. Nomoto to 2 more hospitals, 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Nomoto practices, 6 sites in all. Vendor and product names are available with a free account.

Orthopaedic surgery is Dr. Nomoto's primary specialty in the NPI Registry, under taxonomy code 207X00000X. Dr. Nomoto is board certified in orthopaedic surgery by the American Board of Orthopaedic Surgery. Dr. Nomoto is licensed in California.

Dmand AI lists back and neck pain treatment without fusion, joint cyst, lower back pain, neck pain and spine problems, scoliosis, spinal fusion and thoracic spine disorders among the conditions Dr. Nomoto treats.

CMS data shows 638 Medicare services from Dr. Nomoto across 14 procedure codes in 2024, for 282 Medicare patients. Medicare paid $141,219 for them.

CMS counts 282 Medicare patients who saw Dr. Nomoto in 2024. The largest group is 65 to 74, with 140 patients. 75% of them have arthritis, and 75% have high blood pressure. 19% are also on Medicaid. Their average risk score is 1.20, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Nomoto's median patient age at 69, with 51% women.

In 2024, Dr. Nomoto wrote 280 Medicare Part D claims for 85 patients. 100% of them were for generic drugs. CMS names the drug for 221 of them, across 8 drugs with 11 or more claims each, at $2,684 in total drug cost. In 2023, CMS named 185 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Nomoto for performance year 2024, reported individually. Dr. Nomoto accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Nomoto as offering telehealth. CMS counts 107 procedures of laminectomy or laminotomy (partial removal of spine bones) by Dr. Nomoto, more than 95% of the clinicians it reports for that procedure.

Dmand AI links 1 paper to Dr. Nomoto in 2018. Dr. Nomoto's most frequent co-authors are Justin V. Bundy, MD, Guy R. Fogel, MD and Alexandre Rasouli, MD.

Dmand AI links Dr. Nomoto to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Neck Pain and Paresis.

CMS Open Payments shows 756 general payments to Dr. Nomoto from 36 drug and device companies from 2016 to 2025. Royalties and licenses make up the largest share, 38% of the total. Orthofix Medical, Inc. paid the most, $185,854.

Dr. Nomoto graduated from Stanford University School Of Medicine in 2006.

Dr. Nomoto is in network with 10 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 7. Check the plan with the practice before a visit.